A safety assessment of topical calcineurin inhibitors in the treatment of atopic dermatitis. (Q36784236)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17415290 AND SRC:MED&resulttype=core&format=json

28 December 2019

review article

1 reference

title

A safety assessment of topical calcineurin inhibitors in the treatment of atopic dermatitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17415290 AND SRC:MED&resulttype=core&format=json

28 December 2019

author name string

Mark Lebwohl

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17415290 AND SRC:MED&resulttype=core&format=json

28 December 2019

Tara Gower

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17415290 AND SRC:MED&resulttype=core&format=json

28 December 2019

publication date

10 October 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17415290 AND SRC:MED&resulttype=core&format=json

MedGenMed : Medscape general medicine

28 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17415290 AND SRC:MED&resulttype=core&format=json

28 December 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17415290 AND SRC:MED&resulttype=core&format=json

28 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17415290 AND SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17415290 AND SRC:MED&resulttype=core&format=json

Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children

28 December 2019

cites work

1 reference

12 December 2020

The new topical ascomycin derivative SDZ ASM 981 does not induce skin atrophy when applied to normal skin for 4 weeks: a randomized, double-blind controlled study

1 reference

12 December 2020

Safety and efficacy of nonsteroid pimecrolimus cream 1% in the treatment of atopic dermatitis in infants

1 reference

12 December 2020

1 reference

12 December 2020

Occlusive treatment of chronic hand dermatitis with pimecrolimus cream 1% results in low systemic exposure, is well tolerated, safe, and effective. An open study

1 reference

12 December 2020

Atopic dermatitis management with tacrolimus ointment (Protopic ® )

1 reference

12 December 2020

First experience of topical SDZ ASM 981 in children with atopic dermatitis

1 reference

12 December 2020

SDZ ASM 981: an emerging safe and effective treatment for atopic dermatitis

1 reference

12 December 2020

Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis.

1 reference

12 December 2020

Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis

1 reference

12 December 2020

Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents

1 reference

12 December 2020

Pimecrolimus cream in the long-term management of atopic dermatitis in adults: a six-month study

1 reference

12 December 2020

Tacrolimus ointment for the treatment of atopic dermatitis is not associated with an increase in cutaneous infections

1 reference

12 December 2020

Systemic exposure, tolerability, and efficacy of pimecrolimus cream 1% in atopic dermatitis patients

1 reference

12 December 2020

Toxicology of FK506 in the cynomolgus monkey: a clinical, biochemical, and histopathological study

1 reference

12 December 2020

1 reference

12 December 2020

Topical application of the immunosuppressant tacrolimus accelerates carcinogenesis in mouse skin

1 reference

12 December 2020

Guidelines of care for atopic dermatitis

1 reference

12 December 2020

Long-term safety and tolerability of pimecrolimus cream 1% and topical corticosteroids in adults with moderate to severe atopic dermatitis.

1 reference

12 December 2020

Consensus guidelines in diagnosis and treatment of atopic dermatitis

1 reference

12 December 2020

Characterization of the mononuclear cell infiltrate in atopic dermatitis using monoclonal antibodies

1 reference

12 December 2020

Characterization of the anti-inflammatory effect of FK-506 on human mast cells

1 reference

12 December 2020

The prevalence of childhood atopic eczema in a general population

1 reference

12 December 2020

Effectiveness of the ascomycin macrolactam SDZ ASM 981 in the topical treatment of atopic dermatitis

1 reference

12 December 2020

1 reference

12 December 2020

Tacrolimus ointment does not affect collagen synthesis: results of a single-center randomized trial

1 reference

12 December 2020

A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. Pediatric Tacrolimus Study Group

1 reference

12 December 2020

Ascomycin macrolactam derivative SDZ ASM 981 inhibits the release of granule-associated mediators and of newly synthesized cytokines in RBL 2H3 mast cells in an immunophilin-dependent manner

1 reference

12 December 2020

A novel anti-inflammatory drug, SDZ ASM 981, for the treatment of skin diseases: in vitro pharmacology

1 reference

12 December 2020

The role of topical calcineurin inhibitors in atopic dermatitis

1 reference

12 December 2020

Long-term control of atopic dermatitis with pimecrolimus cream 1% in infants and young children: a two-year study.

1 reference

12 December 2020

Long-term treatment of atopic dermatitis with pimecrolimus cream 1% in infants does not interfere with the development of protective antibodies after vaccination

1 reference

12 December 2020

Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis

1 reference

12 December 2020

A multicenter study of the pharmacokinetics of tacrolimus ointment after first and repeated application to children with atopic dermatitis.

1 reference

12 December 2020

Report of the Topical Calcineurin Inhibitor Task Force of the American College of Allergy, Asthma and Immunology and the American Academy of Allergy, Asthma and Immunology

1 reference

12 December 2020

Tacrolimus ointment 0.03% shows efficacy and safety in pediatric and adult patients with mild to moderate atopic dermatitis

1 reference

12 December 2020

Pneumococcal seroconversion after vaccination for children with atopic dermatitis treated with tacrolimus ointment

1 reference

12 December 2020

Consensus statement on the safety profile of topical calcineurin inhibitors

1 reference

12 December 2020

Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis

1 reference

12 December 2020

Topical calcineurin inhibitors decrease the production of UVB-induced thymine dimers from hairless mouse epidermis

1 reference

12 December 2020

Calcineurin inhibitors decrease DNA repair and apoptosis in human keratinocytes following ultraviolet B irradiation

1 reference

12 December 2020

The use of topical calcineurin inhibitors in dermatology: safety concerns. Report of the American Academy of Dermatology Association Task Force.

1 reference

12 December 2020

Tacrolimus ointment does not affect the immediate response to vaccination, the generation of immune memory, or humoral and cell-mediated immunity in children

1 reference

12 December 2020

Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study Group

1 reference

12 December 2020

Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part I, efficacy

1 reference

12 December 2020

Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part II, safety.

1 reference

12 December 2020

A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients

1 reference

12 December 2020

Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children

1 reference

12 December 2020

The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group

1 reference

12 December 2020

1 reference

12 December 2020

The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis

1 reference

12 December 2020

Identifiers

1 reference